CH565863A5 - - Google Patents

Info

Publication number
CH565863A5
CH565863A5 CH626671A CH626671A CH565863A5 CH 565863 A5 CH565863 A5 CH 565863A5 CH 626671 A CH626671 A CH 626671A CH 626671 A CH626671 A CH 626671A CH 565863 A5 CH565863 A5 CH 565863A5
Authority
CH
Switzerland
Application number
CH626671A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH565863A5 publication Critical patent/CH565863A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255Marek's disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH626671A 1970-04-29 1971-04-28 CH565863A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3306070A 1970-04-29 1970-04-29

Publications (1)

Publication Number Publication Date
CH565863A5 true CH565863A5 (en:Method) 1975-08-29

Family

ID=21868356

Family Applications (1)

Application Number Title Priority Date Filing Date
CH626671A CH565863A5 (en:Method) 1970-04-29 1971-04-28

Country Status (21)

Country Link
US (1) US3642574A (en:Method)
JP (1) JPS4841534B1 (en:Method)
AT (2) AT317606B (en:Method)
BE (1) BE766492A (en:Method)
BR (1) BR7102066D0 (en:Method)
CA (1) CA934295A (en:Method)
CH (1) CH565863A5 (en:Method)
CS (1) CS191868B2 (en:Method)
DE (1) DE2120929B2 (en:Method)
DK (1) DK133311C (en:Method)
ES (1) ES390698A1 (en:Method)
FR (1) FR2092112B1 (en:Method)
GB (2) GB1317710A (en:Method)
HU (1) HU162835B (en:Method)
IE (1) IE35138B1 (en:Method)
IL (1) IL36329A (en:Method)
IT (1) IT1045525B (en:Method)
NL (1) NL165217C (en:Method)
PL (1) PL76295B1 (en:Method)
YU (1) YU35785B (en:Method)
ZA (1) ZA711382B (en:Method)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3965258A (en) * 1974-11-30 1976-06-22 Merck & Co., Inc. Process for production of vaccines
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
JPS6327437A (ja) * 1986-07-17 1988-02-05 Chemo Sero Therapeut Res Inst 鶏伝染病生ワクチン
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
US6303129B1 (en) 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
WO2010008528A2 (en) * 2008-07-18 2010-01-21 The Texas A&M University System Marek's disease virus vaccine compositions and methods of using thereof
CN104602706A (zh) 2012-03-22 2015-05-06 梅里亚有限公司 改性马立克氏病病毒及从其制备的疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens

Also Published As

Publication number Publication date
PL76295B1 (en:Method) 1975-02-28
YU62571A (en) 1980-10-31
IL36329A (en) 1975-04-25
US3642574A (en) 1972-02-15
ZA711382B (en) 1972-11-29
ES390698A1 (es) 1973-07-01
GB1316168A (en) 1973-05-09
GB1317710A (en) 1973-05-23
DK133311C (da) 1976-09-20
AT317606B (de) 1974-09-10
BE766492A (fr) 1971-09-16
IE35138B1 (en) 1975-11-26
BR7102066D0 (pt) 1973-03-13
YU35785B (en) 1981-06-30
DE2120929A1 (de) 1971-11-18
IE35138L (en) 1971-10-29
HU162835B (en:Method) 1973-04-28
CA934295A (en) 1973-09-25
DE2120929B2 (de) 1979-06-28
NL165217C (nl) 1981-03-16
DK133311B (da) 1976-04-26
IT1045525B (it) 1980-05-10
NL165217B (nl) 1980-10-15
FR2092112A1 (en:Method) 1972-01-21
NL7100529A (en:Method) 1971-11-02
JPS4841534B1 (en:Method) 1973-12-07
IL36329A0 (en) 1971-05-26
CS191868B2 (en) 1979-07-31
FR2092112B1 (en:Method) 1974-09-06
AT317421B (de) 1974-08-26

Similar Documents

Publication Publication Date Title
FR2092112B1 (en:Method)
JPS4911161B1 (en:Method)
FI48414B (en:Method)
JPS4916872B1 (en:Method)
FR2117723B3 (en:Method)
FR2055480A5 (en:Method)
JPS487475Y1 (en:Method)
JPS4911165B1 (en:Method)
JPS4819351B1 (en:Method)
JPS4829971B1 (en:Method)
JPS4839788B1 (en:Method)
JPS4819615B1 (en:Method)
JPS4845579Y1 (en:Method)
JPS4840079Y1 (en:Method)
JPS4910093Y1 (en:Method)
JPS488969Y1 (en:Method)
JPS487701Y1 (en:Method)
JPS4827918Y1 (en:Method)
JPS4827959Y1 (en:Method)
JPS4911144B1 (en:Method)
JPS4845490Y1 (en:Method)
JPS4911133B1 (en:Method)
JPS4810802B1 (en:Method)
JPS4916850B1 (en:Method)
JPS4916815Y1 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased